The Valley Desk

NCT02535286 · Interventional trial

Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation

Overall registry status Completed

Phase 1

Conditions Chronic Lymphocytic Leukemia, Richter Syndrome

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov